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The National Institute ofEnvironmental Health Sciences (NIEHS),
with co-sponsorship from the U.S. Environmental Protection Agency
(U.S. EPA), U.S. Food and DrugAdministration/National Center for
Toxicological Research (FDA/NCTR), and the Chemical
Manufacturers Association, held a workshop, "Characterizing the
Effects ofEndocrine Disruptors on Human Health at Environmental
Exposure Levels," in Raleigh, North Carolina, on 11-13 May 1998.
This workshop provided a forum for discussion ofmethods and data
needed to improve risk assessments ofendocrine disruptors, with spe-
cial emphasis on perturbations occurring during critical stages of
development and on characterizing potential health effects at environ-
mental exposure levels. Workshop participants were asked to suggest
ways to make better use ofour current knowledge on endocrine signal-
ing pathways for quantitative evaluations ofpotential linkages between
exposure to chemicals that perturb endocrine function and adverse
health effects.
Reports in the scientific literature and in the media have raised
concerns that certain persistent environmental chemicals may be pro-
ducing adverse effects in wildlife and in humans by interfering with
the endocrine system. Some of the effects include reproductive and
developmental abnormalities, increases in certain hormone-related
cancers (breast, prostate, testis), and declines in wildlife populations.
The term endocrine disruptors is used to describe exogenous agents
that act by mimicking or antagonizing natural hormones in the body
that are responsible for maintaining homeostasis and controlling nor-
mal development. Because hormone receptor systems are similar in
humans and animals, effects observed in wildlife species raise concern
ofpotential human health effects. Evaluating potential low-dose effects
ofenvironmental estrogens was identified as a major research priority
at the 1997 NIEHS conference "Estrogens in the Environment."
The format ofthe present workshop, as well as the specific issues
that needed to be addressed, was conceived by an organizing commit-
tee composed of K. Korach, C. Portier, M. Shelby, and R. Melnick
(chair; NIEHS); R. Kavlock (U.S. EPA); P. Foster (Chemical Industry
Institute ofToxicology); D. Sheehan and B. Delclos (FDA/NCTR);
F. vom Saal (University ofMissouri); and R. Miller (Dow Chemical
Co.). To address the workshop objectives, the organizing committee
identified six breakout group topics:
* Homeostasis and endocrine function in adults
* Endocrine function duringdevelopment
* Species variability, interindividual variability, and tissue specificity
* Dose-response and mechanistic modeling
* Casestudy: estimating riskfromexposure to diethylstilbestrol (DES)
* Case study: estimating risk from environmental exposure to poly-
chlorinated biphenyls (PCBs)
Scientists with expertise in toxicology, endocrinology, cell and
molecular biology, mathematical modeling ofbiologic processes, expo-
sure assessment, and other related fields were invited to participate in
these breakout groups (8 per group). In addition each breakout group
included 8-10 observers who participated in the group discussions. A
series ofquestions was posed to each breakout group as a means of
providing direction on how to address the main theme ofthis work-
shop. Each breakout group was charged with preparing a report that
would provide guidance and recommendations on the use ofmecha-
nistic information on endocrine disruptors that would lead to biologi-
cally based and scientifically credible evaluations ofpotential low-dose
effects ofendocrine disruptors on human health. The term low-dose
was used at this workshop to indicate doses that are likely to be
encountered in the environment.
The first two breakout groups (chaired by G. Stancel and
J. Gorski, respectively) were asked to focus on information needed to
create baseline models describing quantitative relationships among
processes maintaining homeostasis or controlling normal development
and the adequacy ofanimal models and in vitro assays for quantifying
perturbations induced by exogenous agents. The third group (chaired
by C. Walker) addressed issues related to the physiologic and bio-
chemical bases for species and interindividual differences in response
to an endocrine-disrupting chemical and how this information could
be used to assess risk in sensitive subpopulations. The fourth group
(chaired by M. Andersen) focused on the development, value, and use
ofmechanistically based mathematical models that link perturbations
in normal hormone levels and tissue response with external exposure
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to an endocrine-active agent and its target tissue dosimetry. The fifth
and sixth groups (chaired byJ. Cunha and B. Brouwer, respectively)
focused on the extensive exposure and toxicity data on DES and
PCBs and how that information could be used to estimate human
risk resulting from exposure to environmental estrogens or other
environmental agents that act byaltering endocrine functions.
Several overarching issues discussed in the breakout groups indude
the following:
Adequacy ofanimalandin vitro models. Are the currently used
animal models and in vitro models adequate for evaluating potential
effects ofendocrine-active agents in humans with respect to effects on
homeostasis andendocrine function in adults, endocrine function dur-
ing development, and variability in human sensitivity? How well do
effects in animals or in in vitro models represent potential qualitative
and quantitative changes in humans? Do we need newand more sensi-
tive models? What are the research needs that might provide a better
mechanistic understanding ofthe range ofpotential effects in humans?
Utility ofbiologically basedmechanistic models. What information is
needed to create biologically based mathematical models that realisti-
cally represent the physiologic processes affected by endocrine-active
agents? What must be induded in these models to quantify relation-
ships among processes maintaining homeostasis and controlling
normal development, to account for human variability, to evaluate
effects ofendocrine disruptors, and to estimate how exposure to such
agents may alter risks from normal levels ofendogenous hormones?
Can an integrated biologically based mathematical model that
describes relationships among exposure to an endocrine active agent,
tissue dosimetry, tissue interactions, mechanism ofaction, and bio-
logic response lead to more scientifically credible low-dose extrapola-
tions? Ifnot, what research is needed to provide answers that reduce
uncertainties and improve the riskassessment process?
Utility ofbiomarkers. Are there biomarkers identified in some
studies ofendocrine-active agents that may be useful as indicators of
exposure to related compounds or that may reflect changes associated
with increased riskofan adverse effect?
Adequacy ofcurrent testing methodsfordetectinglow-doseefcts. Do
current testing methods examine the most sensitive end points-from
biologic and methodologic perspectives?Are additional tests ormodels
needed to detect andcharacterizelow-dose effects?
Thresholds and low-dose response. Do currently available data
support or deny the existence ofthreshold responses for endocrine-
disrupting chemicals? How do endocrine-active agents affect responses
and alter risks from normal levels ofendogenous hormones?
The following six articles in this issue ofEnvironmental Health
Perspectives Supplements contain peer-reviewed reports from the
workshop breakoutgroups.
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